About
- About Avecho
- Board & Leadership
TPM^® Technology
Portfolio
Invest
- Investor Centre
- Media Centre
Contact

Hit enter to search or ESC to close

Phosphagenics Initiates Arbitration Against Mylan

January 7, 2016

Click here to read more

Post navigation

Phosphagenics’ PHN Trial Completes Enrolment and Dosing

Phosphagenics Reports Positive Resuls for Weaner Pig Efficiency Trial

Related Posts

Phosphagenics Provides Update on TPM Propofol Development Program

November 9, 2017

Avecho reaches two-year stability milestone for its CBD softgel capsule

June 22, 2023June 22, 2023

TGA pre-submission meeting for insomnia related CBD soft-gel product

May 26, 2021May 26, 2021

Recent Posts

Avecho receives US$3M upfront payment from Sandoz AG
March 28, 2025
MEDIA | Ausbiz
March 7, 2025
MEDIA | Stockhead
March 7, 2025

Categories

Analyst Coverage
Company Announcement
Company Report
Investor Webinar
Media Coverage
Newsletter
Press Release
Uncategorised

About us

We see a future where more patients can get even more from their treatments through innovative delivery technologies.

Stay Posted

Stay informed about our latest news and developments.

Leave this field empty if you're human:

About Avecho

TPM^® Technology

Portfolio

Investor Centre
- Investor Centre
- Media Centre

© Copyright 2019 Avecho Biotechnology Ltd.